Endevica Bio's lead drug candidate is a peptide therapeutic for treating cachexia due to cancer and other chronic conditions. The company was formed in 2009 to create best in class peptide drug candidates with better safety and efficacy properties than other drugs in the same class.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.